N.J.-based Amneal Pharmaceuticals could sell for as much as $8 billion

Swiss drug company Novartis AG is nearing an agreement to buy New Jersey-based Amneal Pharmaceuticals for $8 billion. There has not been a decision yet as Amneal could potentially be a target for other suitors, according to Bloomberg News, citing anonymous sources. Amneal, based in Bridgewater, is known for making numerous generic medicines, including gabapentin for epilepsy and pain, and acyclovir, a treatment for herpes as well as. A family-owned business since it was founded in 2002, Amneal…
Source: bizjournals.com Health Care:Biotechnology headlines - Category: Biotechnology Authors: Source Type: news